Trial Profile
Efficacy of Botulinum Toxin A Intradetrusor Injections for the Treatment of Non-neurogenic Urinary Urge Incontinence- A Randomized Double-Blind Control Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Urge incontinence; Urinary incontinence
- Focus Therapeutic Use
- 04 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 28 Oct 2010 New trial record